INSIGHTS

Insights that cut through complexity

New Developments in Macular Degeneration/Diabetic Eye Disease

New Developments in Macular Degeneration/Diabetic Eye Disease

Visual impairment can be a major health issue for older adults, ranging from a minor inconvenience to vision loss significantly…
Drug Innovation Continues Despite a World-Wide Pandemic

Drug Innovation Continues Despite a World-Wide Pandemic

While much of the world was on pause during the COVID-19 pandemic, there are definite signs that even a pandemic…
Three pharmacy trends that will define 2022

Three pharmacy trends that will define 2022

See article as it originally appeared in MedCity News.  The pharmaceutical industry made more headlines in 2021 than in any…
2022 Q1 RemedyOne Quarterly Pipeline Report

2022 Q1 RemedyOne Quarterly Pipeline Report

Download our 2022 Q1  Quarterly Drug Pipeline Report Our quarterly pipeline report provides insight into specialty and traditional drugs in…
High Cost, Lifelong Treatments and the Impact on Payers and Patients

High Cost, Lifelong Treatments and the Impact on Payers and Patients

Healthcare payers may not be familiar with the high costs of paroxysmal nocturnal hemoglobinuria (PNH), or even know what it…
Want the lowest-net-cost drugs? Change your thinking on disruption

Want the lowest-net-cost drugs? Change your thinking on disruption

It might seem like a lowest-net-cost formulary would be made up of clinically equivalent agents with the lowest overall cost.…
Like what you’re seeing? Get more Insights sent to you.
  • This field is for validation purposes and should be left unchanged.